Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability

Table 1

Formulation code for all the batches.

Batch no.	Homogenization speed (1∗1000) rpm	Surfactant concentration (w/v)
A1	5	0.5
A2	5	1.0
A3	5	1.5
B1	10	0.5
B2	10	1.0
B3	10	1.5
C1	15	0.5
C2	15	1.0
C3	15	1.5

Drug (RL-HCL) and lipid (glyceryl behenate) concentration of 20 mg and 100 mg is maintained throughout the study.